BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9839534)

  • 21. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contractility of urinary bladder and vas deferens after sensory denervation by capsaicin treatment of newborn rats.
    Ziganshin AU; Ralevic V; Burnstock G
    Br J Pharmacol; 1995 Jan; 114(1):166-70. PubMed ID: 7712013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroethylclonidine: an irreversible agonist at prejunctional alpha 2-adrenoceptors in rat vas deferens.
    Bültmann R; Starke K
    Br J Pharmacol; 1993 Feb; 108(2):336-41. PubMed ID: 8095416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.
    Dalziel HH; Sneddon P
    Br J Pharmacol; 1988 Jul; 94(3):961-7. PubMed ID: 2846112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BaCl2- and 4-aminopyridine-evoked phasic contractions in the rat vas deferens.
    Huang Y
    Br J Pharmacol; 1995 Jul; 115(5):845-51. PubMed ID: 8548186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of exogenous and endogenous prostaglandins on fast and slow contractions of field-stimulated guinea-pig vas deferens.
    McKay AM; Poyser NL
    Br J Pharmacol; 1995 Nov; 116(6):2679-84. PubMed ID: 8590989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens.
    Lee CM
    Br J Pharmacol; 1985 Nov; 86(3):671-6. PubMed ID: 2998523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRL 37344 inhibited adrenergic transmission in the rat portal vein via atypical beta-adrenoceptors.
    Yousif MH; Oriowo MA
    Pharmacol Res; 2002 Apr; 45(4):313-7. PubMed ID: 12030795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contractile responses of the rat vas deferens after epithelium removal.
    Okpalaugo EO; Garcez-do-Carmo L; Jurkiewicz NH; Jurkiewicz A
    Life Sci; 2002 May; 70(24):2943-51. PubMed ID: 12269404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
    Ralevic V; Burnstock G
    J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of non-adrenergic transmission in the rat vas deferens by prazosin.
    Ebong OO; Zar MA
    Afr J Med Med Sci; 1987 Jun; 16(2):103-7. PubMed ID: 2821775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.
    Driessen B; Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Feb; 108(2):443-7. PubMed ID: 8383564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
    Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
    Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response.
    May JM; Abel PW; Minneman KP
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):324-33. PubMed ID: 2869414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
    Amobi NI; Chung IP; Smith IC
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of postjunctional purinergic mechanisms in the facilitatory action of bradykinin in neurotransmission in the rat vas deferens.
    Donoso MV; Huidobro-Toro JP
    Eur J Pharmacol; 1989 Jan; 160(2):263-73. PubMed ID: 2547629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of acute treatment with sibutramine on the sympathetic neurotransmission of the young rat vas deferens.
    de Souza BP; da Silva ED; Jurkiewicz A; Jurkiewicz NH
    Eur J Pharmacol; 2014 Sep; 738():118-24. PubMed ID: 24886880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens.
    Sum CS; Wan DC; Cheung WT
    Br J Pharmacol; 1996 Jul; 118(6):1523-9. PubMed ID: 8832081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional differences in sympathetic purinergic transmission along the length of the mouse vas deferens.
    Knight D; D'Arbe M; Liang S; Phillips WD; Lavidis NA
    Synapse; 2003 Mar; 47(3):225-35. PubMed ID: 12494405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.